Axial's products improve the quality of patient care, and reduce the cost of providing it, by credentialing the most qualified providers, delivering point of care decision support tools, and utilizing a 360-degree cloud-based predictive model to stratify risk and quantify outcomes. Axial furthers the IHI Triple Aim of driving healthcare value by developing cost-effective, quality-based treatment pathways combined with seamless IT and workflow integration.
The Axial CarePath portal is an innovative, scalable, cloud-based decision support platform driven by predictive intelligence and fueled by evidence-based, peer-reviewed literature and published medical society guidelines. The user time necessary to analyze a request and make a medical- appropriateness determination is less than one minute, with each determination being accompanied by decision rationales, documentation requirements, and changes in risk stratification category when applicable. CarePath also provides a user-friendly means for health systems to collect clinical utilization data in order to better understand trends and drivers in their patient populations.Read More
Axial recognizes through its PharmaView technology that once opioid medication is started, it is many times continued indefinitely with no regard to outcome of other interventions, changes in co- existing morbidities, or adverse events suffered while on therapy. Statistics show that opioid abuse and addiction cost Americans over $484 billion per year and that the direct health care cost to insurers for treating non-medical use of opiates alone exceeds $70 billion annually. Additionally, sixty percent of the more than 15,000 opioid related deaths in the U.S. are not the result of misuse, but rather occur in patients who have received their medication from a single provider and taken it exactly as prescribed. While opioid medication is effective and essential for treating some types of pain in certain patients, numerous studies have shown it to be ineffective in many populations, and in fact, indicate that patients not on opioid therapies are four times more likely to recover from chronic pain. PharmaView collects data, stratifies risk and monitors outcomes from the onset of opioid treatment, and continues to monitor and adjust for risk throughout therapy.Read More
Data shows that clinicians not trained in pain management are providing almost half of the pain procedures performed in many areas of the country, and that their annual rate of increase in utilization is five times that of trained pain physicians. Moreover, non-pain physicians are responsible for the overwhelming majority of opioid prescriptions written in the U.S. To effectively implement best practice protocols and standardize quality-driven patient care, Axial believes that thoroughly credentialing the right provider to perform the most effective procedure at the optimal time via its CredPath technology is the first step in achieving improved clinical outcomes. Continued quality monitoring is accomplished through retrospective audits of clinical practice data and treatment protocols as well as review of procedural imaging studies verifying needle placement.Read More
The CareTrack-360 application simulates the downstream effects linked to changes made in the current treatment pathways. A robust reporting dashboard helps healthcare providers understand and manage the cost drivers behind their utilization and monitor the quality of the care they provide. Additionally, it educates providers about clinical best practices and develops and maintains a roadmap for achieving sustainable quality outcome measurements.
Paul M. McCurry, M.D.
The initiation of the business concept and visionary behind Axial is Dr. Paul McCurry. He is board certified by the American Board of Anesthesiology and has clinical practice experience in anesthesia, interventional pain management and emergency medicine. As an interventional pain management physician, he obtained certification for state-of-the-art minimally invasive spine procedures, measured their quality-based outcomes, and incorporated the results into his clinical algorithm.
As a senior consultant with Quorum Health Resources, the largest hospital management company in the US, Dr. McCurry used his clinical algorithm to work extensively with university teaching hospitals, tertiary care centers, and not-for-profit community hospitals to improve their quality outcomes in surgery and pain management. In these engagements, he served as mediator and contract negotiator between physician groups and hospital executives; analyzed surgical throughput data as it related to national benchmarks, instituted quality assessment of outcomes, and evaluated IT infrastructure data collection techniques. He was a key player on the business development team and assisted QHR in securing their largest contract to date.
In 2004 Dr. McCurry joined MedSolutions as medical director where he has been responsible for shaping national accreditation criteria for radiologists and for the largest network of imaging centers in the US. He has been instrumental in provider network development in new geographic markets by conducting multiple on-site physician forums and supporting client interactions. As subject matter expert, Dr. McCurry contributes to product development for spine imaging and pain management by utilizing evidence-based imaging guidelines.
Dr. McCurry's expertise in pain management, provider credentialing and utilization management enables him to substantially impact the quality and cost associated with this area of medicine. With the founding of Axial Healthcare, he has created a clinical decision support platform that furthers the IHI triple-aim of providing cost-effective, quality-based treatment pathways that improve health care delivery by optimizing patient outcomes while streamlining physician workflow.
John W. Culclasure, M.D.
Dr. Culclasure is Board Certified in Anesthesiology and Pain Management by the American Board of Anesthesiology and is an Adjunct Associate Clinical Professor in the Department of Anesthesiology at Vanderbilt University School of Medicine. He currently practices with The Howell Allen Clinic, a group of twelve neurosurgeons in Nashville, TN.
Dr. Culclasure's clinical interests include minimally-invasive procedures for the treatment of painful spinal conditions as well as the use of implantable devices for the control of intractable pain. Years ago he recognized the importance of evidence-based guidelines and has based his clinical practice on them. He served as chairman of a MCCCC subcommittee created in 2012 at the request of Gov. Bill Haslam to assess and make recommendations about evidenced-based guidelines for workers' compensation in Tennessee.
He is especially concerned about the overuse and abuse of controlled substances among patients with chronic, non-cancer pain. In 2012, he was involved in a review of this topic for the state of Tennessee's Medical Care and Cost Containment Committee (MCCCC) (Department of Labor and Workforce Development Division of Workers' Compensation).
This year, 2013, Dr. Culclasure is a member of a Tennessee Medical Association committee formed to provide guidance to the Tennessee Department of Health on opioid prescribing guidelines for chronic benign pain. The epidemic of overprescribing causes not only fatalities but also morbidity with staggeringly high downstream costs.
He is a member of the American Medical Association, Tennessee Medical Association, Nashville Academy of Medicine (Board of Directors 2012 to present), American Society of Interventional Pain Physicians, Tennessee Society of Interventional Pain Physicians (previously President and Executive Director, currently Treasurer and Board of Directors), International Spinal Injection Society, American Society of Anesthesiologists, and the Tennessee Society of Anesthesiologists. He has been on the Board of Directors of the Tennessee Medical Foundation since 2009, an organization dedicated to providing professional assistance to physicians suffering from chemical dependence, mental or emotional illness.
Dr. Culclasure completed his anesthesiology residency training at Walter Reed ArmyMedical Center, Washington, D.C., in 1989. While at Walter Reed, he was awarded the Robert A. Dripps Memorial Award (annual award to the outstanding resident in anesthesiology).
Dr. Culclasure was born and raised near Charleston, S.C., and is the father of three children. He received his bachelor's degree in Biology from Wofford College in Spartanburg, S.C., and graduated from the Medical University of South Carolina (Charleston) in 1983.